Taro Pharmaceutical Indus Q2 2023 Adj.EPS $0.38 Beats $0.18 Estimate, Sales $148.20M Miss $161.14M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.18 by 111.11 percent. This is a 42.42 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $148.20 million which missed the analyst consensus estimate of $161.14 million by 8.03 percent. This is a 13.57 percent increase over sales of $130.50 million the same period last year.